Rat pancreatic α- and β-cells are critically dependent on hormonal signals generating cyclic AMP (cAMP) as a synergistic messenger for nutrient-induced hormone release. Several peptides of the glucagon-secretin family have been proposed as physiological ligands for cAMP production in β-cells, but their relative importance for islet function is still unknown. The present study shows expression at the RNA level in β-cells of receptors for glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide I(7-36) amide (GLP-I), while RNA from islet α-cells hybridized only with GIP receptor cDNA. Western blots confirmed that GLP-I receptors were expressed in β-cells and not in α-cells. Receptor activity, measured as cellular cAMP production after exposing islet β-cells for 15 min to a range of peptide concentrations, was already detected using 10 pmol/l GLP-I and 50 pmol/l GIP but required 1 nmol/l glucagon. EC50 values of GLP-I- and GIP-induced cAMP formation were comparable (0.2 nmol/l) and 45-fold lower than the EC50 of glucagon (9 nmol/l). Maximal stimulation of cAMP production was comparable for the three peptides. In purified α-cells, 1 nmol/l GLP-I failed to increase cAMP levels, while 10 pmol/l to 10 nmol/l GIP exerted similar stimulatory effects as in β-cells. In conclusion, these data show that stimulation of glucagon, GLP-I, and GIP receptors in rat β-cells causes cAMP production required for insulin release, while adenylate cyclase in α-cells is positively regulated by GIP.
Rapid Publications|
February 01 1996
Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells
Karen Moens;
Karen Moens
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Harry Heimberg;
Harry Heimberg
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Daisy Flamez;
Daisy Flamez
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Peter Huypens;
Peter Huypens
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Erik Quartier;
Erik Quartier
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Zhidong Ling;
Zhidong Ling
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Daniel Pipeleers;
Daniel Pipeleers
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Sandrine Gremlich;
Sandrine Gremlich
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Bernard Thorens;
Bernard Thorens
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Frans Schuit
Frans Schuit
Diabetes Research Center, Vrrje Universiteit Brussel
Brussels, Belgium
Institut de Pharmacologie, Université de Lausanne
Lausanne, Switzerland
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Frans Schuit, Department of Biochemistry, Diabetes Research Center, Faculty of Medicine, Vrye Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. E-mail: [email protected].
Diabetes 1996;45(2):257–261
Article history
Received:
October 27 1995
Revision Received:
November 07 1995
Accepted:
November 07 1995
PubMed:
8549871
Citation
Karen Moens, Harry Heimberg, Daisy Flamez, Peter Huypens, Erik Quartier, Zhidong Ling, Daniel Pipeleers, Sandrine Gremlich, Bernard Thorens, Frans Schuit; Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells. Diabetes 1 February 1996; 45 (2): 257–261. https://doi.org/10.2337/diab.45.2.257
Download citation file: